查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1733240

全球電腦輔助診斷市場規模（依顯像模式、應用、區域範圍）預測（至 2025 年）

Global Computer Aided Diagnosis Market Size By Imaging Modalities, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

電腦輔助診斷市場規模及預測

2024 年電腦輔助診斷市場規模為 7.9233 億美元，預計到 2032 年將達到 12.1121 億美元，2026 年至 2032 年的複合年成長率為 6.01%。

推動全球電腦輔助診斷市場的因素

電腦輔助診斷市場的市場促進因素可能受到多種因素的影響。這些包括：

技術進步：人工智慧 (AI) 演算法和成像模式（例如 MRI、 電腦斷層掃描、X 光）的發展正在提高 CAD 系統的準確性和效率，從而推動其發展。

慢性病盛行率上升：癌症、心血管疾病、神經系統疾病等慢性病盛行率不斷上升，需要早期、準確的診斷。 CAD 系統使這成為可能，推動了市場需求。

老齡人口不斷增加：隨著世界人口老化，需要頻繁進行診斷影像的與老齡化相關的疾病變得越來越普遍。 CAD 系統有助於及早診斷和發現此類問題，從而促進市場擴張。

對於非侵入性診斷程序：電腦輔助診斷系統 (CAD) 提供非侵入性診斷選項，減少患者的不適和與侵入性程序相關的潛在問題。這推動了 CAD 技術的應用，尤其是在乳癌檢測等領域。

政府融資和舉措：提供資金和鼓勵醫療保健基礎設施的發展可以增加 CAD 系統的採用，尤其是在新興經濟體。

醫療保健支出不斷成長：全球醫療保健支出不斷成長，尤其是在已開發國家，這使得醫療機構能夠購買電腦輔助診斷 (CAD) 系統等先進的診斷工具。

高效率醫療服務的需求：CAD 系統可減少診斷錯誤、簡化診斷流程並提高醫療專業人員的工作流程效率。 CAD 技術的採用是由更有效率的醫療保健服務的需求所驅動。

教育和宣傳宣傳活動：有關早期診斷的好處和醫學影像處理技術改進的教育宣傳活動可以提高患者和醫療保健專業人員對 CAD 系統的接受度。

與電子健康記錄(EHR) 系統的整合：透過 CAD 和 EHR 系統的整合實現順暢的資訊交流和決策將提高資料可存取性和互通性，從而有助於推動市場擴張。

限制全球電腦輔助診斷市場的因素

多種因素可能會對電腦輔助診斷市場造成限制和挑戰。具體如下：

投資高：CAD 系統的初始投資通常很高，包括培訓、軟體和硬體的支出。對於醫療機構來說，高昂的實施成本可能是一個主要障礙，尤其是在較貧窮的國家或較小的機構。

整合挑戰：將 CAD 系統與目前的醫療保健基礎設施（包括影像存檔和通訊系統 (PACS) 和電子健康記錄(EHR)）整合可能很困難且成本高昂。相容性問題和互通性困難可能會降低採用率。

監管障礙：用於醫療診斷的 CAD 系統受到嚴格的監管，特別是在資料隱私、安全性和有效性方面。獲得監管部門核准的過程成本高且耗時，這可能會延遲新創意和新產品的上市。

臨床證據有限：儘管 CAD 技術已經取得了進步，但可能沒有足夠有力的臨床證據來支持其在改善患者預後和診斷準確性方面的價值。由於這種不確定性，醫療保健提供者可能不願意廣泛採用 CAD 系統。

依賴專家知識：CAD 系統通常使用由專家創建的資料集訓練的演算法。然而，CAD 演算法的準確性和可靠性取決於這些資料集的品質和代表性。這些資料集可能有所不同，尤其是涉及罕見疾病和不同患者群體時。

工作流程中斷：將 CAD 系統納入臨床工作流程可能會改變既定程序，而醫療保健專業人員需要接受培訓才能正確使用該技術。醫療保健工作者對變革的抵制和對工作流程中斷的擔憂可能會降低採用率。

資料安全問題：CAD 系統處理大量個人病患數據，引發對資料安全、隱私和潛在違規行為的擔憂。對於 CAD 供應商和醫療保健組織來說，確保病患資訊安全並遵守資料保護標準是一項挑戰，但卻是必要的。

目錄

第1章：全球電腦輔助診斷市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章 電腦輔助診斷的全球市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章。全球顯像模式電腦輔助診斷市場

  • 概述
  • 乳房X光攝影
  • 核醫學影像
  • 超音波影像
  • 磁振造影
  • 其他

第6章全球電腦輔助診斷市場（按應用）

  • 概述
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 阿茲海默症
  • 糖尿病視網膜病變
  • 其他

7. 全球電腦輔助診斷市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東和非洲

8. 全球電腦輔助診斷市場競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第9章 公司簡介

  • Hitachi High Technologies Corporation
  • Vucomp
  • Siemens Healthcare
  • EDDA Technology, Inc.
  • McKesson Corporation
  • iCAD, Inc.

第10章 重大進展

  • 產品發布/開發
  • 合併與收購
  • 業務擴展
  • 夥伴關係與合作

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 33698

Computer Aided Diagnosis Market Size And Forecast

Computer Aided Diagnosis Market size was valued at USD 792.33 Million in 2024 and is projected to reach USD 1211.21 Million by 2032, growing at a CAGR of 6.01% from 2026 to 2032.

Global Computer Aided Diagnosis Market Drivers

The market drivers for the Computer Aided Diagnosis Market can be influenced by various factors. These may include:

Technological Advancements: The accuracy and efficiency of CAD systems are being improved by ongoing developments in artificial intelligence (AI) algorithms and imaging modalities (such as MRI, CT scans, and X-rays), which is propelling market expansion.

Growing Prevalence of Chronic Diseases: Early and accurate diagnosis is necessary due to the rising prevalence of chronic diseases such as cancer, cardiovascular disease, and neurological disorders. CAD systems can offer this, which is boosting demand in the market.

Growing Aging Population: As the world's population ages, age-related diseases-which frequently call for diagnostic imaging-are more common. CAD systems promote market expansion by assisting in the early diagnosis and detection of such problems.

for Non-Invasive Diagnostic Procedures: By providing non-invasive diagnostic options, computer-aided diagnostic systems (CAD) lessen patient discomfort and the possibility of invasive procedure-related problems. This is what propels the use of CAD technology, especially in fields like breast cancer detection.

Government financing and Initiatives: The use of CAD systems can be increased by providing financing and encouraging the development of healthcare infrastructure, particularly in emerging economies.

Growing Healthcare Expenditure: The global increase in healthcare spending, particularly in industrialized nations, allows medical facilities to purchase sophisticated diagnostic tools such as computer-aided diagnosis (CAD) systems.

Requirement for Efficient Delivery of Healthcare: CAD systems reduce diagnostic mistakes and streamline the diagnostic process, enhancing workflow efficiency for healthcare practitioners. The adoption of CAD technology is driven by the demand for efficiency in the delivery of healthcare.

Education and Awareness Campaigns: Raising patient and healthcare provider acceptance of CAD systems is facilitated by education campaigns about the advantages of early diagnosis and technological improvements in medical imaging.

Integration with Electronic Health Records (EHR) Systems: The smooth exchange of information and decision-making that results from the integration of CAD and EHR systems improves data accessibility and interoperability and propels market expansion.

Global Computer Aided Diagnosis Market Restraints

Several factors can act as restraints or challenges for the Computer Aided Diagnosis Market. These may include:

High expenditures: The initial investment for CAD systems is frequently substantial and includes expenditures for training, software, and hardware. Healthcare facilities may find this high implementation cost to be a significant obstacle, especially in poor nations or smaller establishments.

Integration Challenges: It can be difficult and expensive to integrate CAD systems with the current healthcare infrastructure, which includes picture archiving and communication systems (PACS) and electronic health records (EHR). Adoption rates may be slowed by compatibility problems and interoperability difficulties.

Regulatory Obstacles: There are strict regulations governing CAD systems used in medical diagnostics, especially with regard to data privacy, safety, and efficacy. The process of obtaining regulatory approval can be costly and time-consuming, which delays the introduction of new ideas and products onto the market.

Limited Clinical Evidence: Although CAD technology has advanced, there may not be enough solid clinical evidence to support its value in enhancing patient outcomes or diagnostic accuracy. Healthcare providers may be reluctant to widely implement CAD systems as a result of this uncertainty.

Dependency on Expertise: CAD systems frequently use algorithms that have been trained using expert-curated datasets. The accuracy and dependability of CAD algorithms are, however, affected by the quality and representativeness of these datasets, which can differ, especially when it comes to rare diseases or varied patient populations.

Workflow Disruption: Integrating CAD systems into clinical workflows may cause established procedures to change, and medical professionals may need to receive training in order to use the technology properly. Adoption rates may be slowed by healthcare workers' resistance to change and worries about interruptions to workflow.

Data Security Issues: Because CAD systems handle vast amounts of private patient data, there are issues with data security, privacy, and possible breaches. For CAD vendors and healthcare institutions, maintaining patient information security and compliance with data protection standards can be difficult yet necessary.

Global Computer Aided Diagnosis Market: Segmentation Analysis

The Global Computer Aided Diagnosis Market is Segmented on the basis of Imaging Modalities, Application, And Geography.

Computer Aided Diagnosis Market, By Imaging Modalities

  • Mammography
  • Nuclear Imaging
  • Ultrasound Imaging
  • Magnetic Resonance Imaging
  • Others

Based on Imaging Modalities, the market is segmented into Mammography, Nuclear Imaging, Ultrasound Imaging, Magnetic Resonance Imaging, and Others. The segment is expected to hold the largest market share. These factors can be attributed to the growing incidence of cancer all over the world. According to the World Cancer Research Fund International 2012, North America and Oceania have the highest breast cancer rate.

Computer Aided Diagnosis Market, By Application

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Alzheimer's Disease
  • Diabetic Retinopathy
  • Others

Based on Application, the market is segmented into Breast Cancer, Lung Cancer, Prostate Cancer, Alzheimer's disease, Diabetic Retinopathy, and Others. The Breast Cancer segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising awareness of regular breast cancer check-ups and the increasing prevalence of cancer.

Computer Aided Diagnosis Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Regional Analysis, the Global Computer Aided Diagnosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to shifting trends from image analysis & pattern recognition algorithms to workflow management functions for diseases & conditions and ongoing research & development in this segment. The Asia Pacific is expected to grow at the highest CAGR due to increasing government initiatives, an upsurge in the demand for medical tourism, and the growing cost-effective technologies in this region.

Key Players

  • The major players in the Computer Aided Diagnosis Market are:
  • Hologic
  • AdvancedMD, Inc.
  • Median Technologies
  • Philips N.V.
  • Canon Medical Systems
  • Hitachi High Technologies Corporation
  • Vucomp
  • Siemens Healthcare
  • EDDA Technology Inc.
  • McKesson Corporation
  • iCAD Inc

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COMPUTER AIDED DIAGNOSIS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY IMAGING MODALITIES

  • 5.1 Overview
  • 5.2 Mammography
  • 5.3 Nuclear Imaging
  • 5.4 Ultrasound Imaging
  • 5.5 Magnetic Resonance Imaging
  • 5.6 Others

6 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Breast Cancer
  • 6.3 Lung Cancer
  • 6.4 Prostate Cancer
  • 6.5 Alzheimer's Disease
  • 6.6 Diabetic Retinopathy
  • 6.7 Others

7 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Hitachi High Technologies Corporation
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Vucomp
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Siemens Healthcare
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 EDDA Technology, Inc.
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 McKesson Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 iCAD, Inc.
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments

10 KEY DEVELOPMENTS

  • 10.1 Product Launches/Developments
  • 10.2 Mergers and Acquisitions
  • 10.3 Business Expansions
  • 10.4 Partnerships and Collaborations

11 Appendix

  • 11.1 Related Research